Telara Pharma designs a drug capable in the treatment and prevention of acute kidney injury.
Telara Pharma has raised $552K in total funding. The most recent round was Equity Crowdfunding. The last funding was announced in October 2026.
Telara Pharma's investors include GENESIS Biomed, ESADE BAN, Keiretsu Forum Spain.
Telara Pharma is headquartered in Barcelona, Spain.
Telara Pharma designs a drug capable in the treatment and prevention of acute kidney injury.
Telara Pharma is at the Equity Crowdfunding stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Telara Pharma — Funding & Investors." VCBacked, October 20, 2026, https://www.vcbacked.co/company/telara-pharma. Accessed November 9, 2026.
VCBacked. (2026). Telara Pharma — Funding & Investors. Retrieved November 9, 2026, from https://www.vcbacked.co/company/telara-pharma
{{cite web |title=Telara Pharma — Funding & Investors |url=https://www.vcbacked.co/company/telara-pharma |website=VCBacked |access-date=November 9, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Telara Pharma? Request a listing update